Legacy Trust boosted its stake in DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 106.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,894 shares of the basic materials company's stock after purchasing an additional 51,097 shares during the quarter. Legacy Trust's holdings in DuPont de Nemours were worth $3,976,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also bought and sold shares of DD. Vanguard Group Inc. raised its position in DuPont de Nemours by 6.7% during the third quarter. Vanguard Group Inc. now owns 50,867,267 shares of the basic materials company's stock valued at $3,962,560,000 after purchasing an additional 3,203,044 shares in the last quarter. State Street Corp raised its position in DuPont de Nemours by 4.8% during the second quarter. State Street Corp now owns 18,363,975 shares of the basic materials company's stock valued at $1,259,585,000 after purchasing an additional 842,852 shares in the last quarter. Invesco Ltd. raised its position in DuPont de Nemours by 28.2% during the third quarter. Invesco Ltd. now owns 8,828,110 shares of the basic materials company's stock valued at $687,710,000 after purchasing an additional 1,942,589 shares in the last quarter. Franklin Resources Inc. raised its position in DuPont de Nemours by 1.4% during the third quarter. Franklin Resources Inc. now owns 7,096,122 shares of the basic materials company's stock valued at $552,788,000 after purchasing an additional 98,590 shares in the last quarter. Finally, Boston Partners raised its position in DuPont de Nemours by 15.1% during the third quarter. Boston Partners now owns 4,007,738 shares of the basic materials company's stock valued at $312,206,000 after purchasing an additional 524,737 shares in the last quarter. 73.96% of the stock is owned by hedge funds and other institutional investors.
DuPont de Nemours Stock Down 0.8%
Shares of NYSE:DD opened at $47.45 on Friday. DuPont de Nemours, Inc. has a 1 year low of $23.36 and a 1 year high of $52.66. The company has a market cap of $19.40 billion, a PE ratio of -25.51, a P/E/G ratio of 1.19 and a beta of 1.09. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.42 and a quick ratio of 1.91. The stock's 50-day moving average is $47.05 and its 200 day moving average is $41.43.
DuPont de Nemours (NYSE:DD - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.03. The business had revenue of ($1,871.00) million for the quarter, compared to the consensus estimate of $1.69 billion. DuPont de Nemours had a negative net margin of 7.03% and a positive return on equity of 7.37%. The company's quarterly revenue was up .2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.13 EPS. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. Sell-side analysts anticipate that DuPont de Nemours, Inc. will post 4.38 EPS for the current year.
DuPont de Nemours Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date of this dividend was Monday, March 2nd. DuPont de Nemours's payout ratio is presently -43.01%.
Wall Street Analysts Forecast Growth
DD has been the topic of several research reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of DuPont de Nemours from $46.00 to $58.00 and gave the stock a "buy" rating in a research note on Wednesday, February 18th. Citigroup lifted their price target on shares of DuPont de Nemours from $50.00 to $59.00 and gave the stock a "buy" rating in a research note on Wednesday, February 11th. Zacks Research raised shares of DuPont de Nemours from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 12th. Argus decreased their price target on shares of DuPont de Nemours from $86.00 to $52.00 and set a "buy" rating on the stock in a research note on Thursday, February 5th. Finally, Mizuho lifted their price objective on DuPont de Nemours from $46.00 to $52.00 and gave the stock an "outperform" rating in a report on Tuesday, February 10th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $51.86.
Get Our Latest Stock Analysis on DuPont de Nemours
DuPont de Nemours Profile
(
Free Report)
DuPont de Nemours NYSE: DD is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont's operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.